Skip to Main Content

Paper Details

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable <i>MYCN</i>-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
J Clin Oncol
7
2020
11q, 1p, 1p loss, Chromosome 1p, Localized Neuroblastoma, MYCN, MYCN-Nonamplified Neuroblastomas, Neuroblastoma, PATIENTS, Patients, SCA, SCAs, Tumor, neuroblastoma, patients, segmental chromosome, stage, stage 2 neuroblastomas, stage 2 tumors, tumors
Author NameAffiliation
Inge M AmbrosChildren's Cancer Research Institute
Olivier DelattreINSERM U
Gudrun SchleiermacherINSERM U
Gudrun SchleiermacherInstitut Curie
Michael D HogartyThe Children's Hospital of Philadelphia
Susan L CohnThe University of Chicago
Ruth LadensteinChildren's Cancer Research Institute
Ruth LadensteinMedical University of Vienna
Jean MichonInstitut Curie
Peter F AmbrosChildren's Cancer Research Institute
Peter F AmbrosMedical University of Vienna
  • 1 - 11

Datasets

Release 1.2